Equity Overview
Price & Market Data
Price: $2.05
Daily Change: $0.00 / 0.00%
Daily Range: $2.05 - $2.05
Market Cap: $71,065,342
Daily Volume: 200
Performance Metrics
1 Week: -22.83%
1 Month: -22.83%
3 Months: -21.35%
6 Months: -31.61%
1 Year: 38.64%
YTD: -22.83%
About Orexo AB (publ) (ORXOY)
Discover key statistics for Orexo AB (publ) (ORXOY). The stock is trading at 2.05, reflecting a daily change of $0.00 / 0.00%. Its market capitalization is 71,065,342. Review its performance history, including 1-week and 1-year trends.
Company Details
Employees: 74
Sector: Health technology
Industry: Pharmaceuticals: major
Country: Sweden
Details
Orexo AB (publ), a pharmaceutical company, provides advance treatments for severe diseases and life-saving rescue medications in the United States, European Union, the United Kingdom, and internationally. Its products include Zubsolv tablets for the treatment of opioid use disorder; Abstral for the treatment of breakthrough pain in cancer patients; Edluar for the treatment of insomnia; and Diabact UBT for the treatment of diagnosis of Helicobacter pylori. The company is developing Izipry for opioid overdose; OX640 to treat anaphylaxis with powder-based epinephrine; OX390 for overdoses caused by a combination of life-threatening illicit drugs; OX125 for opioid overdose with powder-based nalmefene; OX472 for intranasal formulation of semaglutide, a GLP-1 receptor agonist, developed using proprietary AmorphOX technology; and develops thermostable and needle-free mucosal vaccines. Orexo AB (publ) was incorporated in 1994 and is headquartered in Uppsala, Sweden.